Score Overview
PeriodNet IncomeRevenueScoreGrowthTrendConsistencyGrowthTrendConsistency
5 Years
4.3
-4x
60%
—
55.56%
60%
—
5 Years
Score4.3
Net Growth-4x
Net Trend60%
Net Income Consistency—
Rev Growth55.56%
Rev Trend60%
Revenue Consistency—
ImmuCell Corporation fundamental performance
Between 2020 and 2025, revenue grew from $ 15M to $ 27M and net income went from -$ 1M to -$ 1M. Revenue increased in 3 of those 5 years; net income in 3.
Across ImmuCell Corporation's full reported history, from 1989 to 2025, revenue grew from $ 2M to $ 27M and net income went from -$ 1M to -$ 1M. Revenue increased in 68% of the years measured; net income in 55%.
ImmuCell Corporation currently holds a 20-year HDB Score of 4.0 out of 10. How the HDB Score is calculated.
Net Income x Stock Price
Historical Returns
| Period | Price | Return |
|---|---|---|
Last Price2026-08-12 | $ 10.98 | — |
1 Year2025-08-12 | $ 6.65 | 65.11% |
5 Years2021-08-12 | $ 9.34 | 17.61% |
10 Years2016-08-12 | $ 7.54 | 45.63% |
20 Years2006-08-10 | $ 4.97 | 120.93% |
30 Years1996-08-09 | $ 2.88 | 281.91% |
| Period | Last Price2026-08-12 | 1 Year2025-08-12 | 5 Years2021-08-12 | 10 Years2016-08-12 | 20 Years2006-08-10 | 30 Years1996-08-09 |
|---|---|---|---|---|---|---|
| Price | $ 10.98 | $ 6.65 | $ 9.34 | $ 7.54 | $ 4.97 | $ 2.88 |
| Return | — | 65.11% | 17.61% | 45.63% | 120.93% | 281.91% |
Prices are split & dividend adjusted. All values are reported in USD.
Fundamental Data
| Year | |||
|---|---|---|---|
| 2026 | $ 29M | -$ 545.4K | $ 6M |
| 2025 | $ 27M | -$ 1M | $ 3M |
| 2024 | $ 26M | -$ 2M | $ 3M |
| 2023 | $ 17M | -$ 5M | $ 978.74K |
| 2022 | $ 18M | -$ 2M | $ 5M |
| 2021 | $ 19M | -$ 78.29K | $ 10M |
| 2020 | $ 15M | -$ 1M | $ 7M |
| 2019 | $ 13M | -$ 1M | $ 8M |
| 2018 | $ 10M | -$ 2M | $ 2M |
| 2017 | $ 10M | -$ 168K | $ 3M |
| 2016 | $ 9M | $ 508.45K | $ 10M |
| 2015 | $ 10M | $ 1M | $ 6M |
| 2014 | $ 7M | -$ 167.16K | $ 3M |
| 2013 | $ 6M | $ 117.39K | $ 5M |
| 2012 | $ 5M | $ 89.51K | $ 4M |
| 2011 | $ 5M | -$ 409.51K | $ 4M |
| 2010 | $ 4M | -$ 384.68K | $ 4M |
| 2009 | $ 4M | -$ 216.49K | $ 4M |
| 2008 | $ 4M | -$ 468.56K | $ 5M |
| 2007 | $ 6M | $ 662.14K | $ 5M |
| 2006 | $ 4M | $ 647.14K | $ 6M |
| 2005 | $ 4M | $ 707.78K | $ 5M |
| 2004 | $ 3M | $ 143.52K | $ 4M |
| 2003 | $ 3M | $ 411.22K | $ 4M |
| 2002 | $ 6M | $ 886.24K | $ 3M |
| 2001 | $ 6M | $ 420K | $ 1M |
| 2000 | $ 5M | $ 2M | $ 1M |
| 1999 | $ 4M | $ 550.84K | $ 1M |
| 1998 | $ 4M | -$ 100K | $ 1M |
| 1997 | $ 4M | $ 300K | $ 1M |
| 1996 | $ 4M | -$ 100K | $ 1M |
| 1995 | $ 4M | $ 1M | |
| 1994 | $ 4M | -$ 100K | $ 1M |
| 1993 | $ 3M | $ 1M | |
| 1992 | $ 3M | -$ 200K | $ 1M |
| 1991 | $ 2M | -$ 1M | $ 800K |
| 1990 | $ 3M | -$ 600K | $ 900K |
| 1989 | $ 2M | -$ 1M | $ 600K |
Explore beyond ICCC
You're looking at ImmuCell Corporation. Members apply the same fundamental framework across all 3,860 companies we cover.
- Every HDB Score — 1, 5, 10, 20 and 30 years, plus all-time
- Revenue and Net Income Consistency for every period
- Rank all 3,860 companies by any metric, not just three
- Filter by sector and currency, and page through the whole list
- Track your holdings in a portfolio
$99/year $149 founding price
Unlock Holder Dashboard30-day money-back guarantee.
